Pharma Research
It is reported that the multicenter, open-label clinical trial (Phase I/II) is meticulously crafted to systematically evaluate the safety, tolerability, an...
February 06, 2024 | News
Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...
January 30, 2024 | News
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...
January 26, 2024 | News
"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...
January 24, 2024 | News
- Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in ...
January 24, 2024 | News
In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...
January 22, 2024 | News
The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilit...
January 17, 2024 | News
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge geno...
January 15, 2024 | News
The collaboration is centered around platform development and aims to develop a preclinical manufacturing platform, which will facilitate the generation of...
January 11, 2024 | News
- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...
January 08, 2024 | News
Eribulin Mesylate Injection is indicated for patients with locally advanced or metastatic breast cancer who have undergone at least two chemotherapy r...
January 08, 2024 | News
Under the terms of the agreement, MediLink will grant Roche exclusive global rights for the development, manufacturing, and commercialization of MediLink's...
January 03, 2024 | News
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, anno...
January 02, 2024 | News
In just one year since the start of the collaboration, the companies have identified a WT1/HLA-A02-specific T cell engager (WT1xCD3x4-1BB tri-specific anti...
December 28, 2023 | News
Most Read
Bio Jobs
News